Filing Flows › Health Care › SBC Medical Group Holdings (SBC)
SBC Medical Group Holdings (SBC) earnings and revenue breakdown
Latest: Q2 2026 · 10-Q filed Aug 13, 2026 · SBC Medical Group Holdings (SBC) Q2 2026 earnings results →
Q2 2026 Revenue up 13% year over year to $49.2M · 22¢ of every $1 of revenue kept as net profit · operating margin 38.5%
SBC Medical Group Holdings made $49.2M in Q2 2026 (+13% Y/Y): Procurement Services $13.4M, Management Services $12.8M, Waqoo Segment $9.7M. Operating margin 38.5%, net earnings $10.7M. See where every dollar goes — costs, profit and cash — as a Sankey from the 10-Q filed Aug 13, 2026.
Drawing the Sankey…
Open the interactive Sankey → click any line for what the company wrote about it, compare Y/Y and Q/Q, export as PNG or PDF
What changed this quarter
Revenue was $49.2M in Q2 2026, up 13% year over year and up 14% from the previous quarter. Procurement Services was the largest line at 27% of revenue. Management Services added $7.7M year over year (up 150%), 132% of the total change. Rental Services declined 43%.
Gross margin was 73.1%, up 3.9 points from Q2 2025. Operating profit was $19.0M, a 38.5% margin (up 5.0 points year over year). Of the extra revenue versus Q2 2025, 76% reached operating profit, above the 34% margin then. Operating expenses grew 10% against revenue growth of 13%. Net earnings were $10.7M, up 335% year over year. The effective tax rate was 41.2%.
Operating cash flow was $22.5M, 202% of net income including minority interests. Non-cash charges added back $1.1M of depreciation and amortization. Working capital and other items added $10.2M. Capital expenditures of $84K left free cash flow of $22.4M.
Quarterly history
| Quarter | Form | Filed | Revenue | Y/Y | Op. margin | Net earnings | Op. cash flow |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 10-Q | Aug 13, 2026 | $49.2M | +13% | 38.5% | $10.7M | $22.5M |
| Q1 2026 | 10-Q | May 14, 2026 | $43.1M | -9% | 41.2% | $11.3M | $9.2M |
| Q4 2025 | 10-K | Mar 27, 2026 | $39.6M | -11% | 32.5% | $14.2M | $52.0M |
| Q3 2025 | 10-Q | Nov 14, 2025 | $43.4M | -18% | 36.6% | $12.8M | −$20.9M |
| Q2 2025 | 10-Q | Aug 13, 2025 | $43.4M | -18% | 33.6% | $2.5M | −$8.3M |
| Q1 2025 | 10-Q | May 15, 2025 | $47.3M | -14% | 51.1% | $21.5M | $1.9M |
| Q4 2024 | 10-K | Mar 28, 2025 | $44.4M | -29% | 10.6% | $6.5M | −$7.3M |
Charts
Interactive views
The same charts as the app — open one to draw it.
💵Where each $1 goesinteractive
Loading the interactive chart…
🌏Named in Asian annual reportsinteractive
Loading the interactive chart…
🔄Rotation against the market and its industry (RRG)interactive
Loading the interactive chart…
🔍Earnings qualityinteractive
Loading the interactive chart…
⚖️Fair value by methodinteractive
Loading the interactive chart…
🔭Outlook & guidanceinteractive
Loading the interactive chart…
📈Investments: gains and what it boughtinteractive
Loading the interactive chart…
🏭Its industry’s money flow (input-output)interactive
Loading the interactive chart…
About SBC Medical Group Holdings
SBC Medical is a Medical Services Organization providing management support across a wide range of healthcare fields, including advanced aesthetic healthcare, dermatology, orthopedics, fertility treatment, gynecology, dentistry, alopecia treatment (AGA), and ophthalmology. The Company manages a diverse portfolio of clinic brands and is actively expanding its global presence, particularly in the United States and Asia, through both direct operations and medical tourism initiatives. In September 2024, the Company was listed on Nasdaq, and in June 2025, it was selected for inclusion in the Russell 3000® Index, a broad benchmark of the U.S. equity market.
In its own words, from its 8-K, filed Aug 13, 2026.
SBC Medical Group Holdings against its Services-Offices & Clinics of Doctors of Medicine peers
The largest companies of the same SEC industry, each at its latest quarter. Revenue growth: +13% against the peers' median -3%. Operating margin: 38.5% against the peers' median -12.9%.
| Company | Quarter | Revenue | Y/Y | Op. margin |
|---|---|---|---|---|
| SBC SBC Medical Group Holdings | Q2 2026 | $49.2M | +13% | 38.5% |
| HIMS Hims & Hers Health | Q2 2026 | $753M | +38% | -12.9% |
| TDOC Teladoc Health | Q3 2026 | $605M | -3% | -4.6% |
| STLN Starling Oncology | Q3 2026 | $170M | +24% | -1.8% |
| LFMD LifeMD | Q2 2026 | $47.3M | -4% | -15.1% |
| AIRS Airsculpt Technologies | Q3 2026 | $31.9M | -9% | -13.0% |
| CDIX Cardiff Lexington | Q2 2026 | $2.2M | -23% | -25.2% |
| HLYK HealthLynked | Q2 2026 | $250K | -58% | -215.7% |
Source: SBC Medical Group Holdings 10-Q on SEC EDGAR · CIK 1930313 · Services-Offices & Clinics of Doctors of Medicine
13F: who owns SBC and who is buying
More on SBC
History
Every quarter: Q2 2026 results · Q1 2026 results · Q4 2025 results · Q3 2025 results · Q2 2025 results · Q1 2025 results · Q4 2024 results
- SBC Medical Group Holdings gross margin by quarter
- SBC Medical Group Holdings operating margin by quarter
- SBC Medical Group Holdings net income by quarter
- SBC Medical Group Holdings free cash flow by quarter
- SBC Medical Group Holdings capital expenditures by quarter
- SBC Medical Group Holdings Procurement Services revenue by quarter
- SBC Medical Group Holdings Management Services revenue by quarter